Factors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials

• Päätekijät: Ricardo E. da Silva (Tekijä), Angélica A. Amato (Tekijä), Dirce B. Guilhem (Tekijä), Marta R. de Carvalho (Tekijä), Elisangela da C. Lima (Tekijä), Maria Rita C. G. Novaes (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2018-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Although policies and guidelines make use of the concept of vulnerability, few define it. The European Union's directive for clinical trials does not include explanations for or the reasoning behind the designation of certain groups as vulnerable. Emerging economies from lower middl...